288 related articles for article (PubMed ID: 35867523)
1. Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
Kiley PS; Pearston AP; Hodge LA; Kaplan MC; Baczek SM; Stanley JS; Wilson TJ; Soriano KM; Yao A; Shaeffer ZA; Talt IE; Cohen JA; Ingemi AI
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0004022. PubMed ID: 35867523
[TBL] [Abstract][Full Text] [Related]
2. A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients.
Chen AY; Deng CY; Calvachi-Prieto P; Armengol de la Hoz MÁ; Khazi-Syed A; Chen C; Scurlock C; Becker CD; Johnson AEW; Celi LA; Dagan A
Chest; 2023 Aug; 164(2):355-368. PubMed ID: 37040818
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
Buckley MS; Komerdelj IA; D'Alessio PA; Rangan P; Agarwal SK; Tinta NC; Martinez BK; Ziadat DS; Yerondopoulos MJ; Kobic E; Kane-Gill SL
J Crit Care; 2022 Feb; 67():134-140. PubMed ID: 34768175
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis.
Chiu CY; Sarwal A
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109649
[No Abstract] [Full Text] [Related]
5. Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
O'Callaghan K; Hay K; Lavana J; McNamara JF
Int J Antimicrob Agents; 2020 Jul; 56(1):106010. PubMed ID: 32413387
[TBL] [Abstract][Full Text] [Related]
6. Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem.
Rungkitwattanakul D; Ives AL; Harriott NG; Pan-Chen S; Duong L
J Chemother; 2022 Apr; 34(2):103-109. PubMed ID: 34424136
[TBL] [Abstract][Full Text] [Related]
7. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Navalkele B; Pogue JM; Karino S; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Koons J; Hussain T; Perry W; Evans R; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Kaye KS
Clin Infect Dis; 2017 Jan; 64(2):116-123. PubMed ID: 27986669
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
Mullins BP; Kramer CJ; Bartel BJ; Catlin JS; Gilder RE
Ann Pharmacother; 2018 Jul; 52(7):639-644. PubMed ID: 29442542
[TBL] [Abstract][Full Text] [Related]
9. Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
Lee JD; Heintz BH; Mosher HJ; Livorsi DJ; Egge JA; Lund BC
Clin Infect Dis; 2021 Oct; 73(7):e1579-e1586. PubMed ID: 33382398
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.
Blevins AM; Lashinsky JN; McCammon C; Kollef M; Micek S; Juang P
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782987
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
Komerdelj IA; Buckley MS; D'Alessio PA; Ziadat DS; Kobic E; Rangan P; Agarwal SK; Tinta NC; Yerondopoulos MJ; Kane-Gill SL
J Pharm Pract; 2024 Feb; 37(1):80-87. PubMed ID: 36075000
[No Abstract] [Full Text] [Related]
12. [Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
Ide N; Sato S; Sawaguchi K
Yakugaku Zasshi; 2019; 139(12):1609-1614. PubMed ID: 31787651
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Risk Factors of Acute Kidney Injury in Patients Receiving Concomitant Vancomycin and Continuous-Infusion Piperacillin/Tazobactam: A Retrospective Cohort Study.
Blair K; Covington EW
Ann Pharmacother; 2020 Nov; 54(11):1096-1101. PubMed ID: 32406243
[TBL] [Abstract][Full Text] [Related]
15. A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime.
Elliott BP; Tang MM; Madden JA; Markert RJ; Burdette SD; Pleiman CM; Speelmon EC
Intern Emerg Med; 2022 Jan; 17(1):91-99. PubMed ID: 34089468
[TBL] [Abstract][Full Text] [Related]
16. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
17. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime.
Molina KC; Barletta JF; Hall ST; Yazdani C; Huang V
J Intensive Care Med; 2020 Dec; 35(12):1434-1438. PubMed ID: 30741072
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Rutter WC; Burgess DS
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712661
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of area under the concentration-time curve-guided vancomycin dosing with or without piperacillin-tazobactam on the incidence of acute kidney injury.
Muklewicz JD; Steuber TD; Edwards JD
Int J Antimicrob Agents; 2021 Jan; 57(1):106234. PubMed ID: 33232734
[TBL] [Abstract][Full Text] [Related]
20. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
Clemmons AB; Bech CF; Pantin J; Ahmad I
Biol Blood Marrow Transplant; 2018 Apr; 24(4):820-826. PubMed ID: 29292056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
